Jonathan Van Ness is getting candid about his weight loss journey. In a vulnerable new video posted to TikTok this week, the ...
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, Wegovy) is not cost-effective at current pricing, new research shows.
For overweight or obese individuals without diabetes, but with pre-existing cardiovascular disease, semaglutide (Ozempic, ...
More obesity drugs are being launched this year following Novo Nordisk and Eli Lilly's previous successes with GLP-1 drugs.
With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.
As usage of the medications increases, Circana research indicates deli and produce could be bright spots for spending.
As GLP-1 RA use soars, experts are worried that patients may not be getting the right nutrients in their diets. How can ...
Maridebart cafraglutide, a novel injectable GLP-1 receptor agonist/GIP receptor antagonist, reduced body weight by up to ...
Holiday weight gain hits home for many come January. These days, folks making resolutions to slim down and get fit have an ...